Annual Total Long Term Liabilities
$6.74 M
+$334.40 K+5.22%
September 30, 2024
Summary
- As of February 8, 2025, CTXR annual total long term liabilities is $6.74 million, with the most recent change of +$334.40 thousand (+5.22%) on September 30, 2024.
- During the last 3 years, CTXR annual total long term liabilities has risen by +$1.07 million (+18.91%).
- CTXR annual total long term liabilities is now at all-time high.
Performance
CTXR Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$6.74 M
+$80.90 K+1.22%
September 30, 2024
Summary
- As of February 8, 2025, CTXR quarterly total long term liabilities is $6.74 million, with the most recent change of +$80.90 thousand (+1.22%) on September 30, 2024.
- Over the past year, CTXR quarterly long term liabilities has increased by +$80.90 thousand (+1.22%).
- CTXR quarterly long term liabilities is now at all-time high.
Performance
CTXR Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
CTXR Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +5.2% | +1.2% |
| 3 y3 years | +18.9% | +1.2% |
| 5 y5 years | +35.1% | +1.2% |
CTXR Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +18.9% | at high | +22.0% |
| 5 y | 5-year | at high | +35.1% | at high | +618.6% |
| alltime | all time | at high | -100.0% | at high | -100.0% |
Citius Pharmaceuticals Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | $6.74 M(+5.2%) | $6.74 M(+1.2%) |
| Jun 2024 | - | $6.65 M(+1.3%) |
| Mar 2024 | - | $6.57 M(+1.3%) |
| Dec 2023 | - | $6.49 M(+1.3%) |
| Sep 2023 | $6.40 M(+5.9%) | $6.40 M(+1.4%) |
| Jun 2023 | - | $6.31 M(+1.4%) |
| Mar 2023 | - | $6.22 M(+1.5%) |
| Dec 2022 | - | $6.13 M(+1.5%) |
| Sep 2022 | - | $6.04 M(+9.5%) |
| Sep 2022 | $6.04 M(+6.7%) | - |
| Jun 2022 | - | $5.52 M(-0.9%) |
| Mar 2022 | - | $5.57 M(-0.9%) |
| Dec 2021 | - | $5.62 M(-0.8%) |
| Sep 2021 | $5.66 M(-5.7%) | $5.66 M(-0.8%) |
| Jun 2021 | - | $5.71 M(-3.5%) |
| Mar 2021 | - | $5.92 M(-0.7%) |
| Dec 2020 | - | $5.96 M(-0.7%) |
| Sep 2020 | $6.01 M(+20.5%) | $6.01 M(-0.7%) |
| Jun 2020 | - | $6.05 M(+545.3%) |
| Mar 2020 | - | $937.20 K(-4.0%) |
| Dec 2019 | - | $976.20 K(-80.4%) |
| Sep 2019 | $4.99 M(>+9900.0%) | $4.99 M(>+9900.0%) |
| Jun 2019 | - | $0.00(0.0%) |
| Mar 2019 | - | $0.00(0.0%) |
| Dec 2018 | - | $0.00(0.0%) |
| Sep 2018 | $0.00 | $0.00(0.0%) |
| Jun 2018 | - | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $0.00(0.0%) |
| Dec 2017 | - | $0.00(0.0%) |
| Sep 2017 | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | - | $0.00(0.0%) |
| Sep 2016 | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2016 | - | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) |
| Dec 2015 | - | $0.00(0.0%) |
| Sep 2015 | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2015 | - | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) |
| Dec 2014 | - | $0.00(0.0%) |
| Sep 2014 | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2014 | - | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) |
| Dec 2013 | - | $0.00(0.0%) |
| Sep 2013 | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2013 | - | $0.00(0.0%) |
| Mar 2013 | - | $0.00(0.0%) |
| Dec 2012 | - | $0.00(0.0%) |
| Sep 2012 | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2012 | - | $0.00(0.0%) |
| Mar 2012 | - | $0.00(0.0%) |
| Dec 2011 | - | $0.00(0.0%) |
| Sep 2011 | $0.00 | $0.00(0.0%) |
| Jun 2011 | - | $0.00 |
FAQ
- What is Citius Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for Citius Pharmaceuticals?
- What is Citius Pharmaceuticals annual total long term liabilities year-on-year change?
- What is Citius Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Citius Pharmaceuticals?
- What is Citius Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Citius Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of CTXR is $6.74 M
What is the all time high annual total long term liabilities for Citius Pharmaceuticals?
Citius Pharmaceuticals all-time high annual total long term liabilities is $6.74 M
What is Citius Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, CTXR annual total long term liabilities has changed by +$334.40 K (+5.22%)
What is Citius Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of CTXR is $6.74 M
What is the all time high quarterly long term liabilities for Citius Pharmaceuticals?
Citius Pharmaceuticals all-time high quarterly total long term liabilities is $6.74 M
What is Citius Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, CTXR quarterly total long term liabilities has changed by +$80.90 K (+1.22%)